×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Sun Pharmaceuticals
Sun Pharmaceuticals
Sun Pharma: Checkpoint acquisition strengthens speciality portfolio
Buy Sun Pharmaceuticals; target of Rs 2264: Sharekhan
Buy Sun Pharmaceuticals; target of Rs 1800: Sharekhan
Buy Sun Pharmaceuticals; target of Rs 1827: KR Choksey
Sun Pharma, Lupin, Alkem recall products from US market
Sun Pharma hits 52-week high on acquiring Israeli company
Top Nifty gainers and losers at mid-day: Hindalco up, Power Grid down
Improved sentiment, hopes of better sales fuel gains in pharma stocks; Divi's Lab spurts 8%
Taken prompt steps to contain impact of IT security incident, ransomware group claims responsibility: Sun Pharma
Sun Pharma to get growth boost with addition of Deuroxolitinib to its speciality portfolio: Analysts
Quant Pick - Sun Pharmaceuticals: ICICI Direct
Buy Sun Pharmaceuticals; target of Rs 660: Dolat Capital
Buy Sun Pharmaceuticals; target of Rs 571: Dolat Capital
Buy Sun Pharmaceuticals; target of Rs 530: Dolat Capital
Buy Sun Pharmaceuticals; target of Rs 530: Dolat Capital
Hold Sun Pharmaceuticals; target of Rs 460: ICICI Direct
Hold Sun Pharmaceuticals; target of Rs 460: ICICI Direct
Buy Sun Pharmaceuticals; target of Rs 690: ICICI Direct
Sun Pharma recalls over 5.2k units of testosterone cypionate injections from US
Sun Pharmaceuticals Q1 PAT seen up 68.7% YoY to Rs. 886.9 cr: Kotak
Hold Sun Pharmaceuticals; target of Rs 480: Edelweiss
Hold Sun Pharmaceuticals; target of Rs 510: ICICI Direct
Hold Sun Pharmaceuticals; target of Rs 480: Edelweiss
Sun Pharmaceuticals Q2 PAT may dip 62.3% YoY to Rs. 848.7 cr: Kotak
Analysts consensus is bearish on pharma stocks – should one buy?
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio